Los Angeles Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Los Angeles Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,986	Closed	-$47.8K	–	1329
2024 Q2	$47.8K	Buy	+20,986	New	+$80.2K	﹤0.01%	1161
2021 Q4	–	Sell	-11,461	Closed	-$154K	–	1523
2021 Q3	$154K	Hold	11,461	–	–	﹤0.01%	1439
2021 Q2	$251K	Sell	11,461 -34,585	-75%	-$768K	﹤0.01%	1436
2021 Q1	$1.11M	Sell	46,046 -72,265	-61%	-$1.68M	0.01%	846
2020 Q4	$2.13M	Sell	118,311 -21,340	-15%	-$319K	0.01%	638
2020 Q3	$1.61M	Buy	139,651 +18,291	+15%	+$302K	0.01%	640
2020 Q2	$2.94M	Buy	121,360 +60,169	+98%	+$995K	0.01%	514
2020 Q1	$674K	Buy	61,191 +41,755	+215%	+$780K	﹤0.01%	815
2019 Q4	$514K	Buy	+19,436	New	+$455K	﹤0.01%	1010

Los Angeles Capital Management's GTHX Position: Q3 2024 in Review

Los Angeles Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 20,986 shares — an estimated $47.8K sold.

Los Angeles Capital Management first reported a position in GTHX in Q4 2019 and held it in 9 quarters. The position peaked at $2.94M in Q2 2020. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Los Angeles Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Los Angeles Capital Management sold 20,986 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $47.8K.
Los Angeles Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Los Angeles Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $2.94M in Q2 2020.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Los Angeles Capital Management's 13F filing for Q3 2024, filed 4 Nov 2024.